Drug Enforcement D-0398-2025

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

Status

Ongoing

Classification

Class II

Report Date

May 7, 2025

Termination Date

Product Information

Product description
niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for: Civica, Inc., Lehi, UT 84043,Mfd by: American Regent, Inc., New Albany, OH 43064. NDC Carton: 72572-470-10/ NDC Vial: 72572-470-01.
Product quantity
29,777 (cartons of 10 x 10mL vials)
Reason for recall
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA

Location & Firm

Recalling firm
American Regent, Inc.
Address
6610 New Albany Rd E, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0398-2025
Event ID
96695
Recall initiation date
April 18, 2025
Center classification date
May 1, 2025
Code info
Lots, expiry: Lot 24025N0C0, 6/30/2025; Lot 24115N0C0, 10/31/2025; Lot 24116N0C0, 3/31/2026; Lot 24160N0C0, 12/31/2025; Lot 24217N0C0, 01/31/2026; Lot 24288N0C0, 04/30/2026; Lot 24331N0C0, 5/31/2026
More code info